5 of Last Week's Biggest Winners

What's better than momentum? Mo' momentum. Let's take a closer look at five of this past week's biggest scorchers.


April 19

Weekly Gain

Vertex Pharmaceuticals (NASDAQ: VRTX  )


54% (NASDAQ: OSTK  )



Alkermes (NASDAQ: ALKS  )



Sprint Nextel (NYSE: S  )



Actions Semiconductor (NASDAQ: ACTS  )



Source: Barron's.

Let's start with Vertex. The biotech soared after positive mid-stage clinical data for its treatment of cystic fibrosis in patients with a particular mutation. The group taking Vertex's combination performed considerably better than the control group.

Overstock's stock went over well after posting blowout quarterly results. The online discounter's profit of $0.32 a share was well ahead of the $0.12 the website earned a year earlier and the $0.13 analysts were expecting. Revenue also climbed by a robust 19% to $312 million during the period.

Just like Vertex, Alkermes popped on favorable clinical trial results. Alkermes' ALKS-5461 -- an oral opioid modulation drug -- showed promise in a midstage trial for the treatment of major depressive disorder. The sharp move higher excited investors, but at least one analyst felt that the move up may present an opportunity to get out. Mizuho downgraded the stock from "buy" to "neutral" later in the week.

Sprint Nextel moved nicely higher when DISH Network kicked off the week with a rival bid to acquire the country's third largest wireless carrier. DISH wants to be a major telecommunications powerhouse to match the country's two largest players that have invaded the broadband television space. This buyout saga is just beginning.

Finally we have Actions Semiconductor moving up after rolling out a new chip. The Chinese provider of mobile system-on-a-chip solutions introduced the new ATM7023 chipset, which supports the latest Android operating system, giving the company another way to get into gadgetry running the mobile operating system of choice.

Keep the good vibes coming
Are you part of the 99%? The Motley Fool's new free report highlights three less-than-luxurious stocks the 1% may be overlooking. Just click here to read it now.

Read/Post Comments (0) | Recommend This Article (2)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2375146, ~/Articles/ArticleHandler.aspx, 9/25/2016 8:47:14 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 1 day ago Sponsored by:
DOW 18,261.45 -131.01 -0.71%
S&P 500 2,164.69 -12.49 -0.57%
NASD 5,305.75 -33.78 -0.63%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/23/2016 3:58 PM
ACTS $2.08 Down -0.01 -0.48%
Actions Semiconduc… CAPS Rating: No stars
ALKS $49.58 Down -1.42 -2.78%
Alkermes CAPS Rating: ****
OSTK $15.48 Down -0.14 -0.90% CAPS Rating: *
S $6.64 Up +0.02 +0.30%
Sprint CAPS Rating: **
VRTX $90.63 Down -1.49 -1.62%
Vertex Pharmaceuti… CAPS Rating: ****